We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 79 results
  1. A Chewing Study of Abuse-Deterrent Tablets Containing Polyethylene Oxide Using a Robotic Simulator

    Abuse-deterrent formulations (ADFs) refer to formulation technologies aiming to deter the abuse of prescription drugs by making the dosage forms...

    Bangxiang Chen, Feng Zhang, ... Weiliang Xu in AAPS PharmSciTech
    Article 29 November 2023
  2. Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets

    Polyethylene oxide (PEO) is a widely used polymer in the development of abuse-deterrent oral formulations. Different manufacturing processes...

    Leyla Rezaei, Saikishore Meruva, Maureen D. Donovan in AAPS PharmSciTech
    Article 27 December 2021
  3. Mechanical Characterization of Thermally Annealed Tablets Containing Polyethylene Oxide for Abuse Deterrence

    The abuse of prescription opioid drugs is a well-documented and very serious problem. One of the typical first steps an abuser will take is to...

    Elizabeth Tocce, Matthew Bishop, ... Alexis Wontorcik in AAPS PharmSciTech
    Article 11 November 2019
  4. Preferential Oxycodone Loss of Physically Manipulated Abuse Deterrent Oxycodone HCl Extended Release Tablets Prepared for Nasal Insufflation Studies

    A method to reproducibly mill abuse deterrent oxycodone hydrochloride (HCl) extended release (ER) tablets was developed for a nasal insufflation...

    Zhengjie Meng, Heather J. Boyce, ... Tonglei Li in Pharmaceutical Research
    Article 14 June 2021
  5. Use of Drug Release Testing to Evaluate the Retention of Abuse-Deterrent Properties of Polyethylene Oxide Matrix Tablets

    Abuse-deterrent formulations (ADFs) using physical/chemical barrier approaches limit abuse by providing resistance to dosage form manipulation to...

    Saikishore Meruva, Leyla Rezaei, ... Maureen D. Donovan in AAPS PharmSciTech
    Article 06 October 2020
  6. Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidental Overdose or Abuse of Drugs

    Death from an accidental or intentional overdose of sleeping tablets has increased exponentially in the USA. Furthermore, the simultaneous...

    Manali Patki, Siddhant Palekar, ... Ketankumar Patel in AAPS PharmSciTech
    Article 25 November 2020
  7. Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate

    The objective of the present investigation was to understand the effect of sucrose acetate isobutyrate (SAIB) on abuse-deterrent properties (ADPs) of...

    Sogra F. Barakh Ali, Sathish Dharani, ... Ziyaur Rahman in AAPS PharmSciTech
    Article 04 March 2020
  8. Assessing Drug Release from Manipulated Abuse Deterrent Formulations

    There is a need to develop in vitro dissolution methods that discriminate for particle size of the manipulated abuse deterrent formulation (ADF) and...

    Xin Feng, Ahmed Zidan, ... Muhammad Ashraf in AAPS PharmSciTech
    Article 02 January 2020
  9. Polyethylene Oxide (PEO) Molecular Weight Effects on Abuse-Deterrent Properties of Matrix Tablets

    While polyethylene oxide (PEO)-based matrix tablets are frequently used as abuse-deterrent dosage forms, there is limited information available...

    Saikishore Meruva, Maureen D. Donovan in AAPS PharmSciTech
    Article 19 December 2019
  10. Self-regulated Anti-Overdose Crush and Extraction-Resistant Drug Delivery System to Combat Opioid Overdose Crisis

    Pharmaceutical opioid dosage forms are commonly misused via an oral route in non-manipulated form, i.e., overdose in intact form, or manipulated...

    Patel Jayendrakumar, Patel Rakesh in AAPS PharmSciTech
    Article 26 September 2022
  11. Physical Barrier Type Abuse-Deterrent Formulations: Mechanistic Understanding of Sintering-Induced Microstructural Changes in Polyethylene Oxide Placebo Tablets

    The main goal of the presented work was to understand changes in the microstructure of tablets, as well as the properties of its main component viz ....

    Heather J. Boyce, Vivek S. Dave, ... Stephen W. Hoag in AAPS PharmSciTech
    Article 29 January 2020
  12. Evaluation of Abuse-Deterrent Characteristics of Tablets Prepared via Hot-Melt Extrusion

    In this study, the effect of formulation variables and process parameters on the abuse-deterrent (AD) characteristics of a matrix tablet manufactured...

    Xiaoming Xu, Akhtar Siddiqui, ... Muhammad Ashraf in AAPS PharmSciTech
    Article 21 June 2019
  13. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction

    Opioid abuse is a growing problem and has become a national health crisis over the past decade in the USA. Oral ingestion, snorting, and injection...

    Pavan Kumar Nukala, Siddhant Palekar, ... Ketan Patel in AAPS PharmSciTech
    Article 15 January 2019
  14. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats

    Rationale

    Triazole 1.1 is a novel kappa-opioid receptor (KOR) agonist reported to produce antinociception without KOR-typical adverse effects. When...

    C. Austin Zamarripa, Tanya Pareek, ... Kevin B. Freeman in Psychopharmacology
    Article 25 August 2021
  15. Integrated malaria prevention in low- and middle-income countries: a systematic review

    Background

    As many countries aim to eliminate malaria, use of comprehensive approaches targeting the mosquito vector and environment are needed....

    David Musoke, Edwinah Atusingwize, ... Moses R. Kamya in Malaria Journal
    Article Open access 06 March 2023
  16. A Comparison Between Lab-Scale and Hot-Melt-Extruder-Based Anti-inflammatory Ointment Manufacturing

    Hot-melt extrusion (HME) has been extensively investigated for continuous manufacturing of amorphous solid dispersions, to improve the solubility of...

    Rishi Thakkar, Eman A. Ashour, ... Michael A. Repka in AAPS PharmSciTech
    Article 16 July 2020
  17. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys

    Rationale

    Combinations of mu and kappa opioid receptor (KOR) agonists have been proposed as potential analgesic formulations with reduced abuse...

    C. Austin Zamarripa, Jennifer E. Naylor, ... Kevin B. Freeman in Psychopharmacology
    Article 31 January 2020
  18. In Vitro Assessment of Nasal Insufflation of Comminuted Drug Products Designed as Abuse Deterrent Using the Vertical Diffusion Cell

    In vitro evaluation of abuse deterrent formulations (ADFs) is a challenge since real abuse situations are variable and ADF technology is evolving....

    Heather Boyce, Dan Smith, ... Stephen W. Hoag in AAPS PharmSciTech
    Article 26 March 2018
  19. Drivers of Antimicrobial Resistance

    Individuals and healthcare systems all around the globe face a burden related to antimicrobial resistance (AMR) both in terms of their physical...
    Aravind Reghukumar in Handbook on Antimicrobial Resistance
    Living reference work entry 2023
  20. Drivers of Antimicrobial Resistance

    Individuals and healthcare systems all around the globe face a burden related to antimicrobial resistance (AMR) both in terms of their physical...
    Aravind Reghukumar in Handbook on Antimicrobial Resistance
    Reference work entry 2023
Did you find what you were looking for? Share feedback.